Knee OsteoarthritisNCT04418687
Use of the Orthoglide for Improved Patient Outcome Following Total Knee Replacement
A study testing Orthoglide and Physiotherapy only in people with Knee Osteoarthritis and Physiotherapy, run by Ambreen Chohan at 1 site in United Kingdom.
Trial summary
Total knee replacements are a common orthopaedic procedure undertaken at Blackpool Victoria Hospital. Following surgery patients are routinely seen by Physiotherapists who prescribe exercises to improve the range of movement and strength of the knee joint, thus aiding recovery. Read more about this study
- Who is it for?
- Ages 45 to 75 years
- Conditions the study is for
- Knee Osteoarthritis, Physiotherapy, Intervention
- What is being tested?
- Orthoglide and Physiotherapy only
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 31 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 28 Nov 2018to 31 Mar 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients planned to undergo a unilateral total knee replacement at Blackpool Victoria Hospital aged between 45 to 75 years,
- Independently mobile with or without a walking aid.
Who cannot join
- Other lower limb orthopaedic surgery within the last six-months,
- No anticipated further lower limb orthopaedic surgery within the next 12-months,
- No rheumatoid arthritis, neurological conditions affecting lower limb function.
- No Cognitive impairment,
- No co-morbidity which would act as a contraindication to engaging with prescribed exercise
- No existing participation in other clinical trials which may impact rehabilitation outcomes.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Blackpool Victoria Hospital
Blackpool, Lancashire, FY3 8NR
About this study
Official title: Does the Use of an Orthoglide Device Improve Patient Outcome, Following Total Knee Replacement
Total knee replacements are a common orthopaedic procedure undertaken at Blackpool Victoria Hospital. Following surgery patients are routinely seen by Physiotherapists who prescribe exercises to improve the range of movement and strength of the knee joint, thus aiding recovery. One of the key exercises prescribed involves the bending and straightening of the knee to improve range of movement. At this early stage of rehabilitation , due to weakness in the knee joint, reducing any resistance to this motion is beneficial. The Orthoglide device is designed to aid the patient in performing this movement by reducing the friction/resistance caused by the heel sliding against the bed. Currently this is achieved using a 'slider board' and placing a rolled up piece of fabric under the patients heel. The aim of this study is to investigate whether or not issuing an Orthoglide device to patients following total knee replacements improves functional outcomes reported by the patient at 6 weeks and 12 weeks post-surgery. Participants will be assigned to either receive an Orthoglide device and standard Physiotherapy or standard Physiotherapy alone. A series of patient reported outcome measures will be taken pre-surgery, 6 weeks post surgery and 12 weeks post surgery and the results compared.
Read the detailed description
It is hypothesised that issuing an Orthoglide device following total knee replacement will improve patient reported outcomes. The null-hypothesis is that there is no correlation between the issuing of an Orthoglide device and improved patient reported outcome measures post total knee replacement.
The following outlines the various stages which the research participants will pass through during the study:
- Initial contact - having been identified as requiring a total knee replacement the patient will attend Blackpool Victoria Hospital for a routine pre-operative assessment. During this contact the patient will be given an information pack relating to the project, this patient information sheet will include an invitation to participate, information regarding confidentiality, contact information as well as a consent form to be taken away and considered at home.
- Homeward visit - The Homeward team routinely complete home visits with all patients who are awaiting a total knee replacement. During this visit the clinician will further discuss the study and, if the patient wishes to take part, the consent forms may be collected. The visiting clinician will store these sealed envelopes in-line with trust policy on data protection - in a lockable drawer/cabinet upon return to the hospital, this will only be accessible by the Homeward Team and research team.
- Establishing baseline measurements - Consent forms will be reviewed by Robyn Jones and a copy placed in the patients records. Contact details will be recorded on secure access computer folder and participants contacted on preferred telephone number to establish baseline scores of outcome measures, gaining verbal consent prior to commencing. Consent forms will be stored in patients notes via coding with a further copy remaining in a secured storage location only accessible by the research team, for our records. Outcome measure scores will be inputted onto an anonymised and encrypted spreadsheet which will be stored on a password protected computer folder.
- Randomisation - Due to the time period the trial will take place over the investigators will employ block randomisation to allow the participants to be grouped in a timely manner prior to their surgery. Once the participants identity has been anonymised and encrypted participants will be randomised in groups of 10, i.e. every 10 patients recruited will be randomised as one block. This process will repeat for every group of 10 recruited until capacity is reached for the intervention group and the control group. As a feasibility study it is estimated that 30 participants in each arm will be sufficient to give adequate power.
- Identification of participants on weekly operation list - The Orthopaedic Physiotherapy team routinely access operation lists to identify the appropriate patients for Physiotherapy input. These operation lists will be cross referenced with our participant list to identify those taking part in the study and which group participants have been randomised into.
- Patients will attend Blackpool Victoria Hospital for surgery. Routine post-operative Physiotherapy rehabilitation protocols will be followed with the only variation being the issue of an Orthoglide device to those in the study group and not to those in the control group - as identified in stage 5. Patients generally remain an in-patient for approximately 3 days post surgery.
- 6 week follow up call - 6 weeks after the date of surgery (recorded in the secured spreadsheet from the weekly operation list)the research team will contact the patient to complete the outcome measures as used in stage 3, this data will be inputted onto the anonymised and encrypted spreadsheet stored on a password protected computer.
- 12 week follow up call - 12 weeks after the date of surgery the research team will contact the patient to complete the outcome measures as used in stage 3 and 7, this data will be inputted onto the anonymised and encrypted spreadsheet stored on a password protected computer.
- Data analysis and write up - Once all data is collected it will be analysed using the appropriate statistical analysis method and software. This study is designed to cause as little disruption to the routine patient journey as possible. Outside of routine contacts made by the direct care team, the only additional commitments participants must make is to be contacted by telephone by the research team 3 times (pre-operative baseline, 6 week follow-up and 12 week follow-up), each lasting approximately 20-15 minutes. It is estimated that from recruitment a participant will be involved with the study for a maximum of 24 weeks - preoperative clinics must be no more than 12 weeks prior to the surgery and the second follow-up phone call will be 12 weeks post operation. The overall timeframe for the project will be 24 months from April 2018 to April 2020, this includes ethics applications, data collection (to begin from November 2018), analysis and write up. Both arms of the trial will receive the same amount of Physiotherapy input (2 x daily visits) during their in-patient stay.
The only variable will be the issue of an Orthoglide device for the trial group to assist with completion of their knee exercises instead of a 'slider-board'. As a feasibility study no interim reports are planned however as soon as data has been analysed and reported upon it will be made available to the participants. participants will be randomised using block randomisation and data sets anonymised for analysis thus minimising researcher bias by all reasonable means for a study of this nature.
- Conditions
- Knee Osteoarthritis, Physiotherapy, Intervention, Rehabilitation, Exercise
- Being tested
- Orthoglide, Physiotherapy only
- Keywords
- Knee Osteoarthritis, Orthoglide, Knee exercises, KOOS, rehabilitation
- Medical subject headings
- Osteoarthritis, Knee, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
OrthoglideDevice
Knee rehabilitation device.
Physiotherapy onlyOther
Also called Physiotherapy
Physiotherapy only.
| Study group | Role | What they receive |
|---|---|---|
| Physiotherapy only | Active comparator | Standard treatment post Total Knee Arthroplasty Receives: Other: Physiotherapy only |
| Physiotherapy + Orthoglide intervention | Experimental | Standard treatment post TKA, with additional Orthoglide device provided. Receives: Device: Orthoglide |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Knee Osteoarthritis Outcome Score (KOOS)
Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. A better score would be indicated by a higher number closer to 100.
Measured: Change from Baseline to 6 and 12 weeks
Secondary outcomes (2)
Change in Numerical Pain Rating Score (NPRS)
Scored from 0 to 10. Higher scores (closer to 10) indicate a higher level of pain and lower numbers indicate less pain. A minimal clinically important change in NPRS is a 2 point improvement.
Measured: Change from Baseline to 6 and 12 weeks
Change in Exercise Adherence Rating Scale
EARS consists of 6 questions scored on a 5-point Likert scale, with positively worded questions reverse scored, giving a final rating from 0 (lowest adherence) to 24 (highest adherence). Better adherence is sought with any intervention
Measured: Change from Baseline to 6 and 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Jun 2020
- Study start28 Nov 2018
- Primary completion15 Feb 2020
- Study completion31 Mar 2020
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Knee OsteoarthritisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Group 1: Physiotherapy with Orthoglide Group 2: Physiotherapy only
- Masking
- None (open label)
- Enrolment
- 31 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ambreen Chohan
- Sponsor type
- University, hospital or other
- Collaborators
- Blackpool Victoria Hospital
- Responsible party
- Sponsor-investigator, Ambreen Chohan, University of Central Lancashire
- Investigators
- James Richards, PhD, Principal investigator, University of Central Lancashire
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04418687
- Sponsor's protocol ID
- IRAS 235931
- Status last verified
- Jun 2020
- First submitted
- 15 Mar 2020
- Last updated
- 5 Jun 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 5 Jun 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Does the Use of an Orthoglide Device Improve Patient Outcome, Following Total Knee Replacement
- ClinicalTrials.gov ID
- NCT04418687
- Acronym / sponsor ID
- IRAS 235931
- Conditions
- Knee Osteoarthritis, Physiotherapy, Intervention, Rehabilitation, Exercise
- Keywords
- Knee Osteoarthritis, Orthoglide, Knee exercises, KOOS, rehabilitation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 31 participants (actual)
- Lead sponsor
- Ambreen ChohanUniversity, hospital or other
- Collaborators
- Blackpool Victoria Hospital
- Study start
- 28 Nov 2018 (actual)
- Primary completion
- 15 Feb 2020 (actual)
- Study completion
- 31 Mar 2020 (actual)
- First posted
- 5 Jun 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Total knee replacements are a common orthopaedic procedure undertaken at Blackpool Victoria Hospital. Following surgery patients are routinely seen by Physiotherapists who prescribe exercises to improve the range of movement and strength of the knee joint, thus aiding recovery. One of the key exercises prescribed involves the bending and straightening of the knee to improve range of movement. At this early stage of rehabilitation , due to weakness in the knee joint, reducing any resistance to this motion is beneficial. The Orthoglide device is designed to aid the patient in performing this movement by reducing the friction/resistance caused by the heel sliding against the bed. Currently this is achieved using a 'slider board' and placing a rolled up piece of fabric under the patients heel. The aim of this study is to investigate whether or not issuing an Orthoglide device to patients following total knee replacements improves functional outcomes reported by the patient at 6 weeks and 12 weeks post-surgery. Participants will be assigned to either receive an Orthoglide device and standard Physiotherapy or standard Physiotherapy alone. A series of patient reported outcome measures will be taken pre-surgery, 6 weeks post surgery and 12 weeks post surgery and the results compared.
Detailed description
It is hypothesised that issuing an Orthoglide device following total knee replacement will improve patient reported outcomes. The null-hypothesis is that there is no correlation between the issuing of an Orthoglide device and improved patient reported outcome measures post total knee replacement.
The following outlines the various stages which the research participants will pass through during the study:
- Initial contact - having been identified as requiring a total knee replacement the patient will attend Blackpool Victoria Hospital for a routine pre-operative assessment. During this contact the patient will be given an information pack relating to the project, this patient information sheet will include an invitation to participate, information regarding confidentiality, contact information as well as a consent form to be taken away and considered at home.
- Homeward visit - The Homeward team routinely complete home visits with all patients who are awaiting a total knee replacement. During this visit the clinician will further discuss the study and, if the patient wishes to take part, the consent forms may be collected. The visiting clinician will store these sealed envelopes in-line with trust policy on data protection - in a lockable drawer/cabinet upon return to the hospital, this will only be accessible by the Homeward Team and research team.
- Establishing baseline measurements - Consent forms will be reviewed by Robyn Jones and a copy placed in the patients records. Contact details will be recorded on secure access computer folder and participants contacted on preferred telephone number to establish baseline scores of outcome measures, gaining verbal consent prior to commencing. Consent forms will be stored in patients notes via coding with a further copy remaining in a secured storage location only accessible by the research team, for our records. Outcome measure scores will be inputted onto an anonymised and encrypted spreadsheet which will be stored on a password protected computer folder.
- Randomisation - Due to the time period the trial will take place over the investigators will employ block randomisation to allow the participants to be grouped in a timely manner prior to their surgery. Once the participants identity has been anonymised and encrypted participants will be randomised in groups of 10, i.e. every 10 patients recruited will be randomised as one block. This process will repeat for every group of 10 recruited until capacity is reached for the intervention group and the control group. As a feasibility study it is estimated that 30 participants in each arm will be sufficient to give adequate power.
- Identification of participants on weekly operation list - The Orthopaedic Physiotherapy team routinely access operation lists to identify the appropriate patients for Physiotherapy input. These operation lists will be cross referenced with our participant list to identify those taking part in the study and which group participants have been randomised into.
- Patients will attend Blackpool Victoria Hospital for surgery. Routine post-operative Physiotherapy rehabilitation protocols will be followed with the only variation being the issue of an Orthoglide device to those in the study group and not to those in the control group - as identified in stage 5. Patients generally remain an in-patient for approximately 3 days post surgery.
- 6 week follow up call - 6 weeks after the date of surgery (recorded in the secured spreadsheet from the weekly operation list)the research team will contact the patient to complete the outcome measures as used in stage 3, this data will be inputted onto the anonymised and encrypted spreadsheet stored on a password protected computer.
- 12 week follow up call - 12 weeks after the date of surgery the research team will contact the patient to complete the outcome measures as used in stage 3 and 7, this data will be inputted onto the anonymised and encrypted spreadsheet stored on a password protected computer.
- Data analysis and write up - Once all data is collected it will be analysed using the appropriate statistical analysis method and software. This study is designed to cause as little disruption to the routine patient journey as possible. Outside of routine contacts made by the direct care team, the only additional commitments participants must make is to be contacted by telephone by the research team 3 times (pre-operative baseline, 6 week follow-up and 12 week follow-up), each lasting approximately 20-15 minutes. It is estimated that from recruitment a participant will be involved with the study for a maximum of 24 weeks - preoperative clinics must be no more than 12 weeks prior to the surgery and the second follow-up phone call will be 12 weeks post operation. The overall timeframe for the project will be 24 months from April 2018 to April 2020, this includes ethics applications, data collection (to begin from November 2018), analysis and write up. Both arms of the trial will receive the same amount of Physiotherapy input (2 x daily visits) during their in-patient stay.
The only variable will be the issue of an Orthoglide device for the trial group to assist with completion of their knee exercises instead of a 'slider-board'. As a feasibility study no interim reports are planned however as soon as data has been analysed and reported upon it will be made available to the participants. participants will be randomised using block randomisation and data sets anonymised for analysis thus minimising researcher bias by all reasonable means for a study of this nature.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Group 1: Physiotherapy with Orthoglide Group 2: Physiotherapy only
| Arm | Type | Receives |
|---|---|---|
| Physiotherapy only | Active comparator | Other: Physiotherapy onlyStandard treatment post Total Knee Arthroplasty |
| Physiotherapy + Orthoglide intervention | Experimental | Device: OrthoglideStandard treatment post TKA, with additional Orthoglide device provided. |
Who may qualify
- Ages
- 45 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Patients planned to undergo a unilateral total knee replacement at Blackpool Victoria Hospital aged between 45 to 75 years,
- Independently mobile with or without a walking aid.
Key exclusion criteria (6 listed)
- Other lower limb orthopaedic surgery within the last six-months,
- No anticipated further lower limb orthopaedic surgery within the next 12-months,
- No rheumatoid arthritis, neurological conditions affecting lower limb function.
- No Cognitive impairment,
- No co-morbidity which would act as a contraindication to engaging with prescribed exercise
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| OrthoglideKnee rehabilitation device. | Device | Physiotherapy + Orthoglide intervention |
| Physiotherapy onlyAlso: PhysiotherapyPhysiotherapy only. | Other | Physiotherapy only |
Primary outcome
Change in Knee Osteoarthritis Outcome Score (KOOS)
Time frame: Change from Baseline to 6 and 12 weeks
Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. A better score would be indicated by a higher number closer to 100.
2 secondary outcomes
Change in Numerical Pain Rating Score (NPRS)
Time frame: Change from Baseline to 6 and 12 weeks
Change in Exercise Adherence Rating Scale
Time frame: Change from Baseline to 6 and 12 weeks
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jun 2020.
- Individual participant dataSharing planned: No
Related trials for Knee Osteoarthritis
Not yet recruiting
Holistic Healing for Knee Osteoarthritis
Knee Osteoarthritis (Knee OA)
Recruiting
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
Active, not recruitingPhase 2/3
Single vs Triple Hyaluronic Acid in Knee Osteoarthritis
Osteoarthritis, Knee
Not yet recruiting
The Feasibility of a Virtual/Home-based OA Treatment Program in Older Adults With OA and Multimorbidity
Osteoarthritis of the Knee
RecruitingObservational study
Exploring Factors Linked to Worsening Over Time in People With Early-stage Knee Osteoarthritis and Those With Prior Proven Acute Knee Injury.
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
James Richards, PhD principal investigator
University of Central Lancashire
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Orthoglide and Physiotherapy only in people with Knee Osteoarthritis and Physiotherapy, run by Ambreen Chohan at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Knee Osteoarthritis Outcome Score (KOOS) (time frame: Change from Baseline to 6 and 12 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2020.